ALB and metabolic dysfunction-associated steatotic liver disease: To address whether hepatic overexpression of SIRT6 regulates the development of NAFLD, we generated an AAV expressing human SIRT6 under the control of an albumin promoter (AAV8-ALB-hSIRT6).